Fig. 5From: Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsyIn vitro autoradiography of [18F]THK5351 and immunohistochemistry (MAO-B, GFAP, AT8-tau) in frozen sections from subjects. a Basal ganglia from subject 1 and b frontal cortex from subject 2. The specific binding to MAO-B was confirmed by a reversible MAO-B inhibitor, Lazabemide. Scale bars: 5Â mmBack to article page